News
AZ gets EU okay for Tagrisso in early-stage lung cancer
AstraZeneca's EGFR inhibitor Tagrisso has become the first drug in …
20099 items found
News
Sanofi takes SK Bio-partnered pneumococcal shot into phase 3
Sanofi has moved ahead with plans to challenge Pfizer and MSD for a …
R&D
Quality compliance in the digital era
Quality compliance in the pharma industry is foundational to …
News
PBM reform dropped in Congress' funding package
Proposed reforms to the regulations for pharmacy benefit managers …
News
FDA clears Ionis drug as first therapy for rare disease FCS
Ionis Pharma's olezarsen has become the first FDA-approved drug …
News
Lilly grabs first-ever FDA nod for a sleep apnoea drug
Eli Lilly's Zepbound has become the first drug to be FDA-approved for …
News
Novo Nordisk sheds billions in value on obesity data
Less-than-stellar phase 3 results with Novo Nordisk's highly …
Spotlight on
World Without Disease initiative: 2024 update
In a new white paper from the World Without Disease initiative, a …
Sales & Marketing
Why a healthy search strategy can power pharma brand growth
‘Cyber-chondria’ has become an endemic part of our daily lives since …
News
Novartis sheds MorphoSys staff, sites after pelabresib delay
Novartis has said it will shut down two MorphoSys sites in Germany …
News
Vertex weakens after neuropathic pain trial reads out
Vertex Pharma's non-opioid painkiller suzetrigine was unable to …
News
Neuralink rival Precision raises $102m, and other financings
Precision Neurosciences has closed an impressive $102 million …
Focusing too many R&D resources on one drug: The hidden cost...
Drug development is a high-stakes, high-cost endeavour.
Sales & Marketing
Sponsored
Health Trends 2025: Reimagining What's Possible
Join the conversation, on Tuesday 28th January @ 10 am ET - 3 pm GMT - 4 pm CET, in our webinar sponsored by Syneos Health, entitled ‘Health Trends 2025: Reimagining What's Possibl
Digital
Deep Dive: AI 2024
In this issue, we delve into the transformative impact of AI on healthcare and pharma, featuring insights on key AI trends from the floor of Frontiers Health, the ongoing battle against drift, and
Spotlight on
World Without Disease initiative: 2024 update
In a new white paper from the World Without Disease initiative, a 2024 update is provided of the current endeavours and developments that have occurred since inaugural discussions last year
R&D
Precision medicine, NGS, and the quantum leap in biomarkers
In a new pharmaphorum podcast, web editor Nicole Raleigh speaks with Luca Quagliata, Vice President and Global Head of Medical and Scientific Affairs at Thermo Fisher Scientific, a company
Digital
Sponsored
How to deal with fragmented data - A $12.9 million challenge
In the age of AI, large data sets – like the treasure trove of customer data most biopharma companies are sitting on – are an invaluable asset.
R&D
Partner Content
hubXchange returns with its latest series of roundtables!
hubXchange invites you to participate in its highly-anticipated San Diego Series 2025, a series of focused, high-level roundtable events designed to address key challenges and innovations across th
R&D
Partner Content
Advance Best-In-Class Treatment Across CNS, Emergency Use Tr...
With nasal delivery systems offering faster absorption and non-invasive administration, they are becoming a cornerstone of modern therapeutics.
